about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

10 hours ago
Pharma

Volas­tra un­veils first hu­man da­ta of its sol­id tu­mor drug tar­get

19 hours ago
R&D

Up­dat­ed: FDA ex­pects 'time­ly avail­abil­i­ty' of Covid shots as ad­vi­sors up­date for­mu­la rec­om­men­da­tion

Yesterday
FDA+
Coronavirus

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

Yesterday
Pharma
FDA+

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

2 days ago
Pharma
FDA+

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

2 days ago
People

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

3 days ago
R&D
FDA+

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

3 days ago
FDA+
Coronavirus

Up­dat­ed: FDA ap­proves No­vavax's Covid vac­cine af­ter six-week de­lay, but for a small­er pop­u­la­tion

5 days ago
Pharma
FDA+

RFK Jr. adopts new chikun­gun­ya vac­cine guid­ance; oth­er rec­om­men­da­tions re­main un­der re­view

Last week
R&D
Pharma

RFK Jr. says his opin­ions of vac­cines are ‘ir­rel­e­vant.’ For­mer FDA chief Califf dis­agrees

Last week
Pharma
FDA+

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

Last week
Pharma

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Last week
R&D
Pharma

FDA will con­vene vac­cine ad­vi­sors to dis­cuss Covid strain up­dates

3 weeks ago
Pharma
FDA+

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

3 weeks ago
Pharma

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

3 weeks ago
R&D
Pharma

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

3 weeks ago
Pharma
FDA+

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

4 weeks ago
R&D
Pharma

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

4 weeks ago
R&D
Pharma

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

4 weeks ago
China
Pharma

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

4 weeks ago
Pharma

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

4 weeks ago
Pharma
FDA+

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

4 weeks ago
R&D
Pharma

Halozyme sues Mer­ck, al­leg­ing in­jectable Keytru­da will in­fringe its patents

5 weeks ago
Pharma
Law
1234 Next page Last page
A service from the Financial Times